Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Early Feasibility Study of the HighLife 28mm Trans-Septal Transcatheter Mitral Valve Replacement System

NCT04029337 is registered in ClinicalTrials.gov with HighLife SAS as lead sponsor.

NCT NCT04029337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04029337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Early Feasibility Study of the HighLife 28mm Trans-Septal Transcatheter Mitral Valve Replacement System
Lead sponsor
HighLife SAS
Phase
Not applicable
Overall status
Recruiting
Start date
July 14, 2020
Completion date
December 31, 2030
Enrollment
30 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

mitral regurgitation